UBS Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

UBS Group’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$208K	–	11635
2022 Q2	$208K	Hold	10,000	–	–	﹤0.01%	4878
2022 Q1	$168K	Sell	10,000 -1,600	-14%	-$28K	﹤0.01%	5497
2021 Q4	$232K	Buy	11,600 +1,600	+16%	+$30.1K	﹤0.01%	5559
2021 Q3	$181K	Buy	+10,000	New	+$229K	﹤0.01%	5395

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS Group's CVET Position: Q4 2022 in Review

UBS Group sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 2,949,382 shares — an estimated $61.6M sold.

UBS Group first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $61.6M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

UBS Group reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 2,949,382 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $61.6M.
UBS Group first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
UBS Group's Covetrus, Inc. Common Stock position peaked at $61.6M in Q3 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.